EUROPEAN OPEN: NOVOB DC deal-hunting

EUROPEAN OPEN: NOVOB DC deal-hunting, expects 2026 headwinds; US approves NVDA H200 sales to China; Netherlands weighs Nexperia (?? LN) probe; Ahead, key data, central bank speak, potential SCOTUS tariff update

• European equities opened positively, while Chinese stocks faced pressure due to increased margin requirements.
• Oil prices stabilized after recent gains, with geopolitical tensions influencing safe-haven demand for silver and gold.
• Key data releases and central bank commentary are anticipated, with potential updates on US tariffs.

European markets began the day on a positive note, buoyed by gains in Asian equities, particularly the Nikkei 225, which outperformed amid reports of a potential snap election in Japan. However, Chinese equities faced headwinds as authorities increased the minimum margin requirement for financing share purchases, a move aimed at tightening risk controls. This regulatory change affected markets in Shenzhen, Shanghai, and Beijing, contributing to a cautious sentiment among investors.

In commodities, oil prices steadied following a significant four-day rise, the largest in over six months. This stabilization comes as US officials prepare to discuss Iran at a White House meeting, with President Trump warning of "very strong action" if Iran executes protesters. Brent crude hovered near USD 65 per barrel, while WTI crude was around USD 61 per barrel. Analysts attributed the slight decline in oil futures during APAC hours to a technical correction, compounded by bearish API weekly inventory data showing larger-than-expected builds in crude and products.

Precious metals saw notable movements, with silver surging above USD 90 per ounce to fresh highs and gold trading near its all-time high. These gains were supported by geopolitical tensions, particularly in Iran, where President Trump assured protesters that "help is on its way." The persistent uncertainty has bolstered safe-haven demand, driving prices higher.

In the tech sector, Nvidia received US approval to sell H200 AI chips to China, contingent on security assurances and non-military use. However, reports emerged that Chinese authorities instructed customs agents to block these chips from entering the country, adding complexity to Nvidia's operations in the region.

Healthcare companies are also in focus, with Novo Nordisk actively seeking acquisitions to bolster its obesity portfolio following the loss of US biotech Metsera to Pfizer. The company anticipates challenges in 2026 due to potential loss of exclusivity in several markets. Meanwhile, Orion projected strong future sales from its prostate cancer drug Nubeqa, forecasting net sales of EUR 1.9–2.1 billion in 2026.

In the US, retail sales data for November is expected to show a modest increase, with analysts watching for any impact on consumer spending trends. The release of US PPI data and potential updates on Trump tariffs from the Supreme Court are also on the radar, alongside earnings reports from major banks such as Bank of America, Wells Fargo, and Citigroup.

Trader Insight:

• Traders are closely monitoring WTI crude prices following recent inventory data and geopolitical developments.
• Market participants are observing Nvidia (NVDA) amid regulatory challenges in China.
• Some traders may consider positioning in gold and silver as geopolitical tensions drive safe-haven demand.
• Analysts note that traders are watching the XLE ETF for potential energy sector movements.
• Bitcoin's rise to a two-month high is drawing attention from cryptocurrency traders.

Disclaimer: This is not trading advice. For informational purposes only.